Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2026-05-21 @ 4:07 AM
Study NCT ID:
NCT06222593
Status:
RECRUITING
Last Update Posted:
2025-02-17
First Post:
2022-11-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination with Sunitinib in Patients with TKIs-resistant RCC
Sponsor:
State University of New York at Buffalo
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00006224
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None